E-18 Corp. (OTCBB: ETEN), through its wholly owned subsidiary, SquareOne Medical, Inc., doing business as Protectus Medical Devices ("Protectus Medical Devices"), today released an online overview video presented by Dr. John Salstrom, President and CEO of Protectus Medical Devices.
The informative video, entitled “Protectus Medical Devices - Company Overview,” provides a broad summary of Protectus Medical Devices’ competitive advantage as the developer of the only fully automatic, self-sheathing safety hypodermic syringe.
The video is available at: www.trilogy-capital.com/autoir/eten_autoir.html
From the Overview Video:
“Despite current safety precautions, there are an estimated 600,000 to 1 million accidental injuries from conventional syringes and sharps every year in the United States alone, and these are grossly under-reported. The costs of these needlestick injuries weigh heavily on society, in both monetary and human terms.”
Dr. Salstrom goes on to say, “The Protectus Safety Syringe is the only fully automatic, self-sheathing safety hypodermic syringe that currently meets all U.S. Federal Government and OSHA mandates designed to protect both healthcare workers and patients alike. Because the Protectus device is the only Safety Syringe that is automatically self-sheathing, there is a remarkable opportunity for us to capture significant market share.”
The in-depth video presented by Dr. John Salstrom is part of a series of informative videos to be released that will discuss the Company, its revolutionary safety syringe, as well as its ongoing mandate to keep the investment community informed.
The Company's lead product, the Protectus Medical Safety Syringe, is an automatic, self-sheathing hypodermic safety syringe. The Protectus Medical Safety Syringe is designed to significantly reduce or eliminate accidental needlestick injuries that have plagued the healthcare workplace for decades. More information about Protectus Medical Devices may be found at the Company's corporate website at www.protectusmedical.com.